Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on May 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

CFX Opus 96 Real-Time PCR System

Closed
26-003418Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414
DIBBS
Measles, Mumps, and Rubella (MMR) Vaccine Supply and DeliveryThe contract entails the supply and delivery of three units of Measles, Mumps, and Rubella vaccine to a U.S. Navy vessel at a forward operating base destination, with strict requirements for traceable express shipping and full compliance with established medical handling standards. The contractor is responsible for ensuring the vaccines remain viable throughout transit by adhering to temperature control, packaging, and documentation protocols mandated for biological materials. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, with a NAICS code of 325414 indicating pharmaceutical preparation manufacturing. The delivery must be completed in accordance with military logistics guidelines, and all shipping records must maintain a verifiable chain of custody from origin to final receipt aboard the vessel. The contract was posted on August 9, 2026, and the place of performance is tied to a military operational location, though specific geographic details are not provided. The award reference number SPE2DX25D8022 and delivery identifier SPE2D926F8119 are linked to the official DLA procurement system, underscoring the mission-critical nature of timely and secure delivery. While the solicitation number is not listed, the subcontract structure suggests coordination with a prime contractor to fulfill the DOD’s medical readiness requirements. All activities must comply with federal regulations governing vaccine distribution and military supply chain integrity.
Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

N/A

AI Contract Overview

Show more

The U.S. National Institutes of Health is soliciting bids for a CFX Opus 96 Real-Time PCR System under solicitation number 26-003418, with responses due by May 22, 2026 at 10 a.m. Eastern Daylight Time. This is a combined synopsis and solicitation for commercial items issued under FAR Parts 12 and 13, with no written solicitation to follow. The requirement is for a brand-name-or-equal system from Bio-Rad, featuring multiplex nucleic acid detection capability, five-fluorophore simultaneous detection in a single well, a fixed optical path eliminating positional bias, and compact dimensions of 13x22x14 inches to fit under standard lab shelves. The system must provide precise thermal control, reliable fluorescence detection, seamless compatibility with existing CFX laboratory equipment and CFX Maestro software, and support advanced data analysis functions including t-tests and one-way ANOVA. The award will be made on a firm-fixed-price basis, with evaluation based primarily on technical capability and past performance, significantly outweighing cost considerations. All offerors must submit required commercial item representations and certifications, including completion of FAR 52.212-3 via SAM.gov, and adherence to the applicable FAR clauses and addenda outlined in the document. The contract will be performed in Bethesda, Maryland, and is unrestricted with a NAICS code of 334516 and a small business size standard of 1,000 employees.

General Info

NIH seeks proposals for CFX Opus 96 PCR system; evaluation based on technical merit, performance, cost.

Agency

Department Of Health And Human Services → National Institutes Of Health OlaoView Agency

NAICS

325414 - Biological Product (except Diagnostic) ManufacturingView NAICS

Place of Performance

CA, 94547, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
View Agency Profile
Office AddressBETHESDA, MD, 20892, USA

Full Description

Show more

COMBINED SYNOPSIS / SOLICITATION WORKFORM



(1)    Action Code: Combined Synopsis/Solicitation
(2)    Date: May 12
(3)    Year: 2026
(4)    Contracting Office Zip Code: 20817
(5)    Classification Code: 6640
(6)    Contracting Office Address:
6701 Rockledge Drive
Bethesda, MD 20817
(7)    Subject/Title: CFX Opus 96 Real-Time PCR System
(8)    Solicitation Number: 26-003418
(9)    Closing Response Date: May 22, 2026 @ 10am. Eastern Daylight Time (EDT)
(10)    Contact Point(s): Towanda Daniels, Purchasing Agent
(11)    Contract Award Type: Firm Fixed Price
(12)    Brand Name or Equal Acquisition (FAR 52.211-6): Yes
(13)    Description: 
(i)    “This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a written solicitation will not be issued.”


(ii)    The solicitation number and a statement that the solicitation is issued as a request for quote (RFQ).


(iii)    The solicitation document, the incorporated provisions, and clauses are those in effect through Federal Acquisition Circular, FAC Number: 2026-01
Effective Date: 03/13/2026


(iv)    This solicitation is being released unrestricted. The NAICS code is 334516, and the small business size standard is 1000 employees. This acquisition is being conducted in accordance with the procedures of FAR Part 12 and FAR Part 13.


(v)    The equipment consists of a real-time PCR system capable of supporting multiplex nucleic acid detection and analysis. The system must provide accurate thermal control, reliable fluorescence detection, and compatibility with existing laboratory software and experimental workflows.
 
The following product features/characteristics are required for this requirement:  
 
System can capture up to five fluorophores in a single reaction well using “All 
Channels” scan mode, or, for faster scanning time, one fluorophore when using the SYBRR/FAM or FRET Scan Modes. 


Fixed optical path, directly over each well, eliminates the need to normalize for positional bias or passive dye calibration. 


System does not have lid or drawer that extends beyond the footprint of the system nor requires additional operating clearance. 


Dimensions (W x D x H) is 13x22x14 inches; can easily fit under a standard shelf 


Real-time data traces can be viewed during a run from the thermal cycler base or on CFX Maestro (if a computer is connected to the instrument). 


CFX Maestro software is compatible with all real time PCR results from the older model CFX system the lab has been using; it shall ensure project continuity. 


Multiple plates can be combined into one experiment with the Gene Study Feature on the free CFX Maestro software. 


Software performs t-tests and 1-way ANOVA calculations. 


The requested system, from Bio-Rad shall provide multiplexing capability, thermal uniformity, and compatibility with existing laboratory workflows and data analysis software to support current and future research requirements. 


The provisions at FAR Clause 52.212-1, Instructions to Offerors – Commercial Items, applies to this acquisition. The following addendum related to the Instructions to Offerors is included:


Addendum to FAR Clause 52.212-1, Instructions to Offerors – Commercial Items. Please refer to this addendum for additional attachments, including the Statement of Work and other relevant information.


Evaluations will be conducted in accordance with the provision at FAR Clause 52.212-2. Offerors will be evaluated as follows:


EVALUATION-COMMERCIAL ITEMS (OCT 2014)
(a)    The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers:


•    Technical
•    Past Performance
•    Cost


All evaluation factors other than cost or price, when combined are significantly more important than cost or price.



Written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.


Please refer to the addendum for additional evaluation information.


Each Offeror must include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications – Commercial Items, with its offer.


Please note, each Offeror shall complete only paragraph (b) of this provision if the Offeror has completed the annual representations and certification electronically via the System for Award Management (SAM) website located at
https://www.sam.gov/portal.


FAR Clause 52.212-4, Contract Terms and Conditions – Commercial Items, applies to this acquisition. The terms and conditions outlined in the following addendum also apply:


Addendum to FAR Clause 52.212-4, Contract Terms and Conditions – Commercial Items. Please refer to this addendum for additional terms and conditions related to the requirement.


FAR Clause 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders – Commercial Items, applies to this acquisition. The full text version of FAR 52.212-5 included in the addenda as Attachment 5 indicate which FAR clauses and provisions are applicable to this acquisition.



    Contact Information:


Towanda Daniels
Email: danielt@mail.nih.gov 


(14)    Place of Contract Performance: Bethesda, MD
(15)    Set-aside Status: N/A


More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS